{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:21:46Z","timestamp":1790961706135,"version":"4.1.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":387,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The study aims to examine characteristics and outcomes associated with health-related quality of life (HRQoL) in patients with heart failure (HF) with preserved, mildly reduced and reduced ejection fraction (EF) (HFpEF, HFmrEF and HFrEF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Data on HRQoL were collected in the Swedish Heart Failure Registry (SwedeHF; 2000\u20132021) using the EuroQoL 5-dimensional visual analogue scale (EQ 5D-vas). Baseline EQ 5D-vas scores were categorized as \u2018best\u2019 (76\u2013100), \u2018good\u2019 (51\u201375), \u2018bad\u2019 (26\u201350) and \u2018worst\u2019 (0\u201325). Independent associations between patients' characteristics and EQ 5D-vas, as well as between EQ 5D-vas and outcomes were assessed. Of 40 809 patients (median age 74 years; 32% female), 29% were in the \u2018best\u2019, 41% in the \u2018good\u2019, 25% in the \u2018bad\u2019 and 5% in the \u2018worst\u2019 EQ 5D-vas categories, similarly distributed across all EF categories. Higher New York Heart Association (NYHA) class was strongly associated with lower EQ 5D-vas regardless of EF categories, followed by chronic obstructive pulmonary disease, smoking, body mass index, higher heart rate, anaemia, previous stroke, ischaemic heart disease, use of diuretics and living alone, whereas higher income, male sex, outpatient status and higher systolic blood pressure were inversely associated with lower EQ 5D-vas categories. Patients in the \u2018worst\u2019 EQ 5D-vas category as compared with the \u2018best\u2019 had the highest risk of all-cause death [adjusted hazard ratios 1.97, 95% confidence interval (CI) 1.64\u20132.37 in HFrEF, 1.77, 95% CI 1.30\u20132.40 in HFmrEF and 1.43 95% CI 1.02\u20132.00 in HFpEF].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Most patients were in the two highest EQ 5D-vas categories. Higher NYHA class had the strongest association with lower EQ 5D-vas categories, across all EF categories. Patients in the worst EQ 5D-vas category were at the highest risk of mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.15206","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T01:35:10Z","timestamp":1738028110000},"page":"1977-1991","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Health-Related Quality of Life Across Heart Failure Categories: Associations with Clinical Characteristics and Outcomes"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5045-9125","authenticated-orcid":false,"given":"Camilla","family":"Settergren","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Karolinska Institutet , Stockholm ,","place":["Sweden"]},{"name":"Heart and Vascular Theme, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Benson","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Karolinska Institutet , Stockholm ,","place":["Sweden"]},{"name":"Department of Clinical Science and Education, S\u00f6dersjukhuset, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Dahlstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Link\u00f6ping University , Link\u00f6ping ,","place":["Sweden"]},{"name":"Department of Health, Medicine and Caring Sciences, Link\u00f6ping University , Link\u00f6ping ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonje","family":"Thorvaldsen","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Karolinska Institutet , Stockholm ,","place":["Sweden"]},{"name":"Heart and Vascular Theme, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Savarese","sequence":"additional","affiliation":[{"name":"Department of Clinical Science and Education, S\u00f6dersjukhuset, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H.","family":"Lund","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Karolinska Institutet , Stockholm ,","place":["Sweden"]},{"name":"Heart and Vascular Theme, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahira","family":"Shahim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Karolinska Institutet , Stockholm ,","place":["Sweden"]},{"name":"Heart and Vascular Theme, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"2026021804232669500_ehf215206-bib-0001","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026021804232669500_ehf215206-bib-0002","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/heart.87.3.235","article-title":"Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables","volume":"87","author":"Juenger","year":"2002","journal-title":"Heart"},{"key":"2026021804232669500_ehf215206-bib-0003","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.hrtlng.2008.04.002","article-title":"Quality of life in patients with heart failure: ask the patients","volume":"38","author":"Heo","year":"2009","journal-title":"Heart Lung"},{"key":"2026021804232669500_ehf215206-bib-0004","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1053-2498(01)00298-4","article-title":"Preferences for quality of life or survival expressed by patients with heart failure","volume":"20","author":"Lewis","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"2026021804232669500_ehf215206-bib-0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQol: the current state of play","volume":"37","author":"Brooks","year":"1996","journal-title":"Health Policy"},{"key":"2026021804232669500_ehf215206-bib-0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101592","article-title":"Association between disease-specific health-related quality of life and all-cause mortality in patients with heart failure: a meta-analysis","volume":"48","author":"Xu","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"2026021804232669500_ehf215206-bib-0007","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.120.050850","article-title":"Health-related quality of life and mortality in heart failure: the Global Congestive Heart Failure Study of 23 000 patients from 40 countries","volume":"143","author":"Johansson","year":"2021","journal-title":"Circulation"},{"key":"2026021804232669500_ehf215206-bib-0008","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ejhf.1149","article-title":"Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum","volume":"20","author":"Lund","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026021804232669500_ehf215206-bib-0009","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41569-021-00605-5","article-title":"Heart failure with mid-range or mildly reduced ejection fraction","volume":"19","author":"Savarese","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2026021804232669500_ehf215206-bib-0010","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026021804232669500_ehf215206-bib-0011","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41572-024-00540-y","article-title":"Heart failure with preserved ejection fraction","volume":"10","author":"Hamo","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"2026021804232669500_ehf215206-bib-0012","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003358","article-title":"Exploring new endpoints for patients with heart failure with preserved ejection fraction","volume":"9","author":"Butler","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026021804232669500_ehf215206-bib-0013","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/03009734.2018.1490831","article-title":"The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failure","volume":"124","author":"Savarese","year":"2019","journal-title":"Ups J Med Sci"},{"key":"2026021804232669500_ehf215206-bib-0014","volume-title":"SWEDEHEART annual report 2022 SwedeHF appendix"},{"key":"2026021804232669500_ehf215206-bib-0015","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026021804232669500_ehf215206-bib-0016","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","article-title":"The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research","volume":"24","author":"Ludvigsson","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"2026021804232669500_ehf215206-bib-0017","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","article-title":"The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research","volume":"34","author":"Ludvigsson","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"2026021804232669500_ehf215206-bib-0018","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCHEARTFAILURE.113.000359","article-title":"Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction","volume":"6","author":"Joseph","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026021804232669500_ehf215206-bib-0019","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1177\/09622802231198795","article-title":"Logistic regression vs. predictive mean matching for imputing binary covariates","volume":"32","author":"Austin","year":"2023","journal-title":"Stat Methods Med Res"},{"key":"2026021804232669500_ehf215206-bib-0020","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","article-title":"Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state-of-the-art review","volume":"76","author":"Spertus","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026021804232669500_ehf215206-bib-0021","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jchf.2018.02.006","article-title":"Comparing measures to assess health-related quality of life in heart failure with preserved ejection fraction","volume":"6","author":"Napier","year":"2018","journal-title":"JACC Heart Fail"},{"key":"2026021804232669500_ehf215206-bib-0022","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejheart.2005.01.012","article-title":"The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study","volume":"7","author":"Calvert","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"2026021804232669500_ehf215206-bib-0023","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017278","article-title":"Change of health-related quality of life over time and its association with patient outcomes in patients with heart failure","volume":"9","author":"Sepehrvand","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2026021804232669500_ehf215206-bib-0024","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/ejhf.2508","article-title":"Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure)","volume":"24","author":"McNaughton","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026021804232669500_ehf215206-bib-0025","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/ejhf.2535","article-title":"Factors associated with health-related quality of life in heart failure in 23 000 patients from 40 countries: results of the G-CHF research programme","volume":"24","author":"Johansson","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026021804232669500_ehf215206-bib-0026","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jchf.2019.05.015","article-title":"Health-related quality of life in heart failure with preserved ejection fraction: the PARAGON-HF Trial","volume":"7","author":"Chandra","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2026021804232669500_ehf215206-bib-0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102217","article-title":"Changing health related quality of life and outcomes in heart failure by age, sex and subtype","volume":"64","author":"Lawson","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2026021804232669500_ehf215206-bib-0028","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/heartjnl-2020-316793","article-title":"Income level and outcomes in patients with heart failure with universal health coverage","volume":"107","author":"Hung","year":"2021","journal-title":"Heart"},{"key":"2026021804232669500_ehf215206-bib-0029","first-page":"698","article-title":"Income and heart disease: Neglected risk factor","volume":"61","author":"Lemstra","year":"2015","journal-title":"Can Fam Physician"},{"key":"2026021804232669500_ehf215206-bib-0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejheart.2006.10.012","article-title":"Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM","volume":"9","author":"Lewis","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"2026021804232669500_ehf215206-bib-0031","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/2047487318755795","article-title":"Factors associated with health-related quality of life in stable ambulatory congestive heart failure patients: Systematic review","volume":"25","author":"Baert","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"2026021804232669500_ehf215206-bib-0032","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S1053-2498(00)00117-0","article-title":"Predictors of quality of life in women with heart failure. SOLVD Investigators. Studies of left ventricular dysfunction","volume":"19","author":"Riedinger","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"2026021804232669500_ehf215206-bib-0033","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/ejhf.3263","article-title":"Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced\/preserved ejection fraction","volume":"26","author":"Yang","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026021804232669500_ehf215206-bib-0034","first-page":"523","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"75","author":"McDonagh","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/3\/1977\/66955865\/eschf_12_3_1977.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/3\/1977\/66955865\/eschf_12_3_1977.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T09:23:35Z","timestamp":1771406615000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/12\/3\/1977\/8488299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,1,27]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15206","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"2024-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}